Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 43

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 43
---
 will also disclose whether any of the selling security
holders have held any position or office with, have been employed by, or otherwise have had a material relationship with us during the
three years prior to the date of the prospectus supplement.

<div align='center'>12

DESCRIPTION OF SECURITIES TO BE REGISTERED</div>

The descriptions of the securities contained in
this prospectus, together with the applicable prospectus supplements, summarize the material terms and provisions of the various types
of securities that we may offer. We will describe in the applicable prospectus supplement relating to any securities the particular terms
of the securities offered by that prospectus supplement. If we so indicate in the applicable prospectus supplement, the terms of the securities
may differ from the terms we have summarized below. We will also include in the prospectus supplement information, where applicable, about
material U.S. federal income tax considerations relating to the securities, and the securities exchange, if any, on which the securities
will be listed.

We may sell from time to time common stock, preferred
stock, debt securities, warrants to purchase any such securities, or any combination of the foregoing.

In this prospectus, we refer to the common stock,
preferred stock, debt securities, and warrants to be sold by us collectively as “securities.”

If we issue debt securities at a discount from
their original stated principal amount, then we will use the issue price, and not the principal amount, of such debt securities for purposes
of calculating the total dollar amount of all securities issued under this prospectus.

This prospectus may not be used to consummate
a sale of securities unless it is accompanied by a prospectus supplement.

<div align='center'>13

DESCRIPTION OF COMMON STOCK</div>

We are authorized to issue up to 110,000,000 shares
of capital stock, of which 100,000,000 are shares of common stock, par value $0.00001 per share, and 10,000,000 shares of preferred stock,
$0.00001 par value, of which 20,000 have been designated as Series A Super Voting Preferred Stock, $0.00001 par value (the “Super
Voting Preferred Stock”). As of January 4, 2024, there were 4,308,822 shares of our common stock outstanding and 6,000 shares of
our Super Voting Preferred Stock outstanding.

Common Stock

The holders of our common stock are entitled to
the following rights:

V